Coloplast A/S Stock
Stocks
COLO B
DK0060448595
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 417.90 DKK | -0.26% |
|
-0.62% | -23.52% |
| 09-09 | JP Morgan cuts Coloplast, puts Ambu and Elekta on negative watch - BN | FW |
| 09-09 | JP Morgan downgrades Coloplast to underweight (neutral) - BN | FW |
| Market Cap | 94.1B 14.26B 12.58B 11.92B 10.75B 20.29B 1,367B 20.53B 143B 54.89B 700B 53.55B 52.38B 2,244B | P/E 2026 * |
26.9x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 115B 17.36B 15.3B 14.5B 13.09B 24.69B 1,663B 24.98B 173B 66.79B 852B 65.17B 63.74B 2,731B | EV / Sales 2026 * |
3.97x | EV / Sales 2027 * | 3.69x |
| Free-Float |
63.42% | Yield 2026 * |
4.89% | Yield 2027 * | 5.2% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| COLO B | Delayed | |
CBOE
| COLOBc | Real-time | |
|
Tradegate
| CBHD | Real-time | |
|
Xetra
| CBHD | Delayed | |
|
London S.E.
| 0QBO | Delayed | |
|
Berne S.E.
| 020259063 | End-of-day quote | |
|
Boerse Muenchen
| CBHD | Real-time | |
|
Deutsche Boerse AG
| CBHD | Delayed | |
|
OTC Markets
| CLPBF | Delayed | |
|
CBOE
| 0QBO | Real-time | |
|
Wiener Boerse
| COLO | End-of-day quote | |
|
Börse Stuttgart
| CBHD | Delayed |
Last Transcript: Coloplast A/S
| 1 day | -0.26% | ||
| 1 week | -0.62% | ||
| Current month | -8.91% | ||
| 1 month | -9.68% | ||
| 3 months | +10.67% | ||
| 6 months | -2.84% | ||
| Current year | -23.52% |
| 1 week | 411.9 |  | 424.9 |
| 1 month | 411.9 | | 483.5 |
| Current year | 369.7 | | 584.2 |
| 1 year | 369.7 | | 631.4 |
| 3 years | 369.7 | | 977.6 |
| 5 years | 369.7 | | 1,194 |
| 10 years | 369.7 | | 1,194 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Wood
CEO | Chief Executive Officer | 55 | 2026-04-30 |
| Director of Finance/CFO | 54 | 2005-12-31 | |
Allan Rasmussen
COO | Chief Operating Officer | 59 | 2008-09-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 2006-12-12 | |
Thomas Barfod
BRD | Director/Board Member | 56 | 2009-09-17 |
| Chairman | 58 | 2025-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/22 | Buy | Company | 27,398 | 0.0138% | ||
| 4/4/22 | Buy | Company | 393,288 | 0.1986% | ||
| 3/28/22 | Buy | Company | 3,552 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -0.62% | -24.21% | -44.10% | 14.3B | |
| -2.10% | -4.69% | -25.75% | +2.04% | 175B | |
| -0.92% | -4.94% | -8.17% | +10.12% | 111B | |
| -0.90% | +0.11% | -25.55% | +0.78% | 107B | |
| +0.69% | +0.76% | -47.04% | -11.84% | 75.31B | |
| -2.39% | -4.51% | -2.54% | +66.83% | 58.7B | |
| -1.63% | -2.19% | -2.72% | -30.76% | 49.57B | |
| +1.53% | +4.31% | +15.99% | +53.87% | 49.27B | |
| -2.11% | +0.13% | -17.19% | +19.42% | 42.02B | |
| -0.40% | -3.62% | +29.84% | -7.51% | 32.69B | |
| Average | -0.52% | -0.66% | -10.73% | +5.88% | 71.49B | |
| Weighted average by Cap. | -0.27% | -1.12% | -15.77% | +7.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.86B 4.37B 3.86B 3.65B 3.3B 6.22B 419B 6.3B 43.7B 16.83B 215B 16.42B 16.06B 688B | 30.79B 4.67B 4.12B 3.9B 3.52B 6.64B 447B 6.72B 46.63B 17.96B 229B 17.52B 17.14B 734B |
| Net income | 3.71B 563M 496M 470M 424M 800M 53.9B 810M 5.62B 2.16B 27.62B 2.11B 2.07B 88.52B | 5.84B 885M 781M 740M 668M 1.26B 84.85B 1.27B 8.85B 3.41B 43.47B 3.32B 3.25B 139B |
| Net Debt | 20.4B 3.09B 2.73B 2.58B 2.33B 4.4B 296B 4.45B 30.9B 11.9B 152B 11.61B 11.36B 487B | 19.59B 2.97B 2.62B 2.48B 2.24B 4.22B 284B 4.27B 29.66B 11.43B 146B 11.15B 10.9B 467B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | DKK 417.90 | -0.26% | 334,274 |
| 26-09-29 | DKK 419.00 | -0.43% | 279,690 |
| 26-09-28 | DKK 420.80 | +0.77% | 323,630 |
| 26-09-25 | DKK 417.60 | -0.71% | 362,766 |
| 26-09-24 | DKK 420.60 | +0.24% | 282,768 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLO B Stock
Select your edition
All financial news and data tailored to specific country editions
